A critical breakthrough in cancer research is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently inactivated in several forms of cancer, leading https://bookmarksea.com/story21898349/vhh-fragments-revive-the-p53-protein-the-promising-pathway-for-malignant-management